Lincoln Pharma vs Morepen Labs vs Inventurus: Which Stock Should You Track
- October 5, 2026
- Posted by: Neeraj Pandey
- Category: Market
Lincoln Pharmaceuticals PE 12.09, mkt cap Rs 1,166 crore. Morepen Laboratories PE 52.02, mkt cap Rs 7,326 crore. Inventurus Knowledge Solutions PE 39.92, mkt cap Rs 30,486 crore.
Quick Answer
Lincoln Pharmaceuticals vs Morepen Laboratories vs Inventurus Knowledge Solutions is a side-by-side comparison of three companies from the Pharma and Healthcare Services space. On this comparison, Lincoln Pharmaceuticals carries a market capitalisation of about Rs 1,166 crore against Rs 7,326 crore for Morepen Laboratories and Rs 30,486 crore for Inventurus Knowledge Solutions, with return on equity of 11.60%, 5.96% and 25.77% respectively. Each company’s numbers are presented here without a declared better pick, since the right stock depends on an investor’s own criteria.
Lincoln Pharmaceuticals vs Morepen Laboratories vs Inventurus Knowledge Solutions starts with the core numbers most investors compare within the Pharma and Healthcare Services segment: market capitalisation, valuation multiples, profitability and dividend yield. Figures below are sourced as of September 2026 and will shift with daily price moves.
All three names sit in the Pharma and Healthcare Services bucket, which makes them a natural set to place side by side rather than a random trio of unrelated businesses.
Click Here – Get Free Investment Predictions
Lincoln Pharmaceuticals, Morepen Laboratories and Inventurus Knowledge Solutions: Company Overview
Lincoln Pharmaceuticals is a listed Indian company in the Pharma and Healthcare Services space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.
Morepen Laboratories is a listed Indian company in the Pharma and Healthcare Services space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.
Inventurus Knowledge Solutions is a listed Indian company in the Pharma and Healthcare Services space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.
Lincoln Pharmaceuticals vs Morepen Laboratories vs Inventurus Knowledge Solutions: Valuation and Profitability Snapshot
| Metric | Lincoln Pharmaceuticals | Morepen Laboratories | Inventurus Knowledge Solutions |
|---|---|---|---|
| Market Cap (approx.) | Rs 1,166 crore | Rs 7,326 crore | Rs 30,486 crore |
| PE Ratio (TTM) | 12.09 | 52.02 | 39.92 |
| PB Ratio | 1.54 | 5.88 | 10.89 |
| Return on Equity (ROE) | 11.60% | 5.96% | 25.77% |
| EPS (TTM, Rs) | 48.15 | 2.57 | 44.49 |
| Dividend Yield | 0.31% | 0.15% | 0.00% |
| Debt to Equity | 0.01 | 0.17 | 0.27 |
| Book Value per Share (Rs) | 378.25 | 22.75 | 163.10 |
Check the Univest Screener for Live Data
On valuation, Lincoln Pharmaceuticals trades at a PE of 12.09 and a PB of 1.54, Morepen Laboratories at a PE of 52.02 and a PB of 5.88, while Inventurus Knowledge Solutions trades at a PE of 39.92 and a PB of 10.89. On return on equity, the three post 11.60%, 5.96% and 25.77% respectively, and on dividend yield they stand at 0.31%, 0.15% and 0.00%.
Lincoln Pharmaceuticals vs Morepen Laboratories vs Inventurus Knowledge Solutions: Latest Quarterly Results
| Company | Latest Quarter Revenue | Latest Quarter Net Profit | YoY Change (Revenue) | QoQ Change (Revenue) |
|---|---|---|---|---|
| Lincoln Pharmaceuticals | Rs 201.54 crore | Rs 36.23 crore | +19.0% | +10.1% |
| Morepen Laboratories | Rs 575.31 crore | Rs 56.35 crore | +33.9% | +16.7% |
| Inventurus Knowledge Solutions | Rs 899.34 crore | Rs 193.74 crore | +21.0% | +4.3% |
Quarterly figures above are the most recent reported quarter for each company (Q1 FY27, quarter ended June 2026), compared with the year-ago and preceding quarter.
Download the Univest iOS App or Univest Android App to track Lincoln Pharmaceuticals, Morepen Laboratories and Inventurus Knowledge Solutions live prices.
What Should Investors Look at Beyond These Numbers?
Beyond the metrics above, investors comparing these three pharma and healthcare services names should track quarter-on-quarter revenue and margin trends, management commentary on demand and cost drivers, and any sector-specific regulatory developments, since a single-quarter snapshot can shift quickly.
Conclusion
Lincoln Pharmaceuticals vs Morepen Laboratories vs Inventurus Knowledge Solutions highlights how differently three companies in the same pharma and healthcare services segment can score across valuation, profitability and dividend metrics, even when operating in a similar space. This comparison does not declare a winner; investors should weigh these figures against their own research and risk appetite. Please read the disclaimer below before making any investment decision.
Disclaimer: Data and figures in this article are sourced from publicly available information as of September 2026 and may not reflect real-time prices. Please verify all data independently before making any investment decision. This comparison does not recommend or endorse any single stock over another; investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Lincoln Pharmaceuticals vs Morepen Laboratories vs Inventurus Knowledge Solutions
What is the market cap difference between Lincoln Pharmaceuticals, Morepen Laboratories and Inventurus Knowledge Solutions?
Ans. As of September 2026, Lincoln Pharmaceuticals has a market cap of approximately Rs 1,166 crore, Morepen Laboratories is at approximately Rs 7,326 crore, and Inventurus Knowledge Solutions is at approximately Rs 30,486 crore.
Which of the three has the highest PE ratio?
Ans. Among Lincoln Pharmaceuticals, Morepen Laboratories and Inventurus Knowledge Solutions, the PE ratios stand at 12.09, 52.02 and 39.92 respectively as of September 2026.
Which of the three has the highest ROE?
Ans. Lincoln Pharmaceuticals, Morepen Laboratories and Inventurus Knowledge Solutions post ROE of 11.60%, 5.96% and 25.77% respectively as of September 2026.
Which of these three stocks pays the highest dividend yield?
Ans. Lincoln Pharmaceuticals, Morepen Laboratories and Inventurus Knowledge Solutions carry dividend yields of 0.31%, 0.15% and 0.00% respectively.
What is the debt to equity ratio for Lincoln Pharmaceuticals, Morepen Laboratories and Inventurus Knowledge Solutions?
Ans. Lincoln Pharmaceuticals carries a debt to equity of 0.01, Morepen Laboratories of 0.17, and Inventurus Knowledge Solutions of 0.27.
Which of the three trades at the highest price to book value?
Ans. Lincoln Pharmaceuticals, Morepen Laboratories and Inventurus Knowledge Solutions trade at price to book ratios of 1.54, 5.88 and 10.89 respectively.
Is one of Lincoln Pharmaceuticals, Morepen Laboratories or Inventurus Knowledge Solutions better than the others?
Ans. This comparison does not declare one stock better than another; each company scores differently across valuation, profitability and dividend metrics, and the right fit depends on an individual investor’s own criteria and research.
